IE42427L - STEROIDAL [16Ó,17Ó-b] 1,4-DIOXANES - Google Patents
STEROIDAL [16Ó,17Ó-b] 1,4-DIOXANESInfo
- Publication number
- IE42427L IE42427L IE750078A IE7875A IE42427L IE 42427 L IE42427 L IE 42427L IE 750078 A IE750078 A IE 750078A IE 7875 A IE7875 A IE 7875A IE 42427 L IE42427 L IE 42427L
- Authority
- IE
- Ireland
- Prior art keywords
- phenyl
- alkyl
- aryl
- tetrahydropyran
- yloxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D319/00—Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D319/10—1,4-Dioxanes; Hydrogenated 1,4-dioxanes
- C07D319/12—1,4-Dioxanes; Hydrogenated 1,4-dioxanes not condensed with other rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
- C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0046—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa
- C07J5/0061—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16
- C07J5/0092—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond substituted in position 17 alfa substituted in position 16 by an OH group free esterified or etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/008—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21
- C07J7/0085—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms substituted in position 21 by an halogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1498132 Steroid [16α,17-b]dioxanes E R SQUIBB & SONS Inc 15 Jan 1975 [16 Jan 1974] 1776/75 Headings C2U and C2C The invention comprises 3,20-dioxo pregnenes having an 11#-hydroxy or 11-oxo group and having at position 16,17 a fused-on 1,4-dioxane or dihydro - 1,4 - dioxin ring. Preferred are the #<SP>4</SP>, #<SP>1,4</SP>, #<SP>4,6</SP> and #<SP>1,4,6</SP> compounds of formula wherein A 1 is selected from (the valence on the left being attached to the 17-oxygen atom); R 1 is H, C 1-8 alkyl, or aryl; R 2 is H, C 1-8 alkyl or aryl-(C 1-8 alkyl); R 3 is C 1-8 alkyl, C 3-6 cycloalkyl, or aryl; R 4 and R 5 are each C 1-8 alkyl, or aryl; P is H, Me or Cl; Q is H, Me or F; X is H or halo; Y is H, Y<SP>1</SP> is OH or Y + Y<SP>1</SP> = oxo; Z is H, halo, OH or acyloxy; the term "aryl" signifying phenyl optionally sub stituted with one or more halo, C 1-8 alky or C 1-8 alkoxy groups. The inventive compounds are prepared from analogous 16α,17α-diol cyclic borates by synthesizing the 16,17-dioxane ring as shown in the reaction scheme infra, and subsequently optionally introducing #<SP>6</SP> unsaturation (e.g. with DDQ) acylating at position 21 (this may also be effected on the intermediates marked * and **), hydrolysing a 21-ester group, or converting 21- OH to 21-halo via a 21-sulphonate (this may also be effected on the intermediate marked **) (R 1 , R 3 , R 4 , R 5 and Z are as above; R 6 is alkyl or aryl; R 7 is alkyl or aralkyl; each X is alkyl or the two X's together are ethylene). Reagents: (a) CH 2 :C(R 1 )N 2 ; (b) (XO) 2 C(R 4 )C(R 5 )N 2 ; (d) THP.O.CH 2 CHN 2 ; (e) m-chloroperhenzoic acid; (f) e.g. periodic acid; (g) e.g. f-toluenesulphonic acid; (h) NaBH 4 ; (i) MeSO 2 Y (Y= halo); (j) NaHCO 3 /DMSO; (k) e.g. HCl; (1) (R 3 CO) 2 O; (m) Fetizon's reagent; (n) e.g. acetic acid; (p) tautomerism. A 16,17-cycloborate is prepared from 21-chloro- 9 - fluoro - 11#,16α,17 - trihydroxypregna - 1,4- diene - 3,20 - dione by reaction with boric oxide in methanol. Potassium phthalimide + α - (bromomethyl) styrene # N - (2 - phenyl - 2 - propenyl)phthalimide # ethyl N - (2 - phenyl - 2 - propenyl) carbamate # ethyl N - nitroso - N - (2 - phenyl - 2- propenyl)carbamate # 2 - phenyl - 3 - diazo - 1- propene (Example 4). 2 - (Tetrahydropyran - 2 - yloxy)acetonitrile # 2 - (tetrahydropyran - 2 - yloxy)ethylamine # N - [2 - (tetrahydropyran - 2 - yloxy)ethyl]urea # N - nitroso - N - [2 - (tetrahydropyran - 2 - yloxy) ethyl]urea # 2 - (tetrahydropyran - 2 - yloxy) - 1- diazoethane (Example 18). Potassium phthalimide + α-bromopropiophenone # N - (1 - methyl - 2 - oxo - 2 - phenylethyl) phthalimide # 2 - (1 - phthalimidoethyl) - 2- phenyl - 1,3 - dioxolane # 2 - (1 - aminoethyl) - 2- phenyl - 1,3 - dioxolane # 2 - phenyl - 2 - [1- (ethoxycarbonylamino)ethyl] - 1,3 - dioxolane # 2 - phenyl - 2 - (1 - diazoethyl) - 1,3 - dioxolane (Example 40). Antiinflammatory compositions for oral and topical administration comprise a compound of Formula I and a carrier.
[GB1498132A]
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43397474A | 1974-01-16 | 1974-01-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
IE42427L true IE42427L (en) | 1975-07-16 |
IE42427B1 IE42427B1 (en) | 1980-08-13 |
Family
ID=23722311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IE78/75A IE42427B1 (en) | 1974-01-16 | 1975-01-15 | Steroidal 1,4-dioxanes |
Country Status (20)
Country | Link |
---|---|
JP (1) | JPS50101358A (en) |
AR (1) | AR209758A1 (en) |
BE (1) | BE824405A (en) |
CA (1) | CA1050966A (en) |
CH (1) | CH606116A5 (en) |
CS (1) | CS182829B2 (en) |
DD (1) | DD117449A5 (en) |
DE (1) | DE2501041A1 (en) |
DK (1) | DK9075A (en) |
ES (1) | ES433814A1 (en) |
FI (1) | FI750090A (en) |
FR (2) | FR2257299B1 (en) |
GB (1) | GB1498132A (en) |
IE (1) | IE42427B1 (en) |
IL (1) | IL46436A (en) |
NL (1) | NL7500458A (en) |
NO (1) | NO750119L (en) |
SE (1) | SE7500430L (en) |
SU (1) | SU581874A3 (en) |
ZA (1) | ZA75298B (en) |
-
1975
- 1975-01-13 DE DE19752501041 patent/DE2501041A1/en not_active Withdrawn
- 1975-01-15 CS CS7500000281A patent/CS182829B2/en unknown
- 1975-01-15 JP JP50006984A patent/JPS50101358A/ja active Pending
- 1975-01-15 NO NO750119A patent/NO750119L/no unknown
- 1975-01-15 BE BE152397A patent/BE824405A/en unknown
- 1975-01-15 AR AR257302A patent/AR209758A1/en active
- 1975-01-15 DK DK9075*BA patent/DK9075A/da unknown
- 1975-01-15 DD DD183650A patent/DD117449A5/xx unknown
- 1975-01-15 ZA ZA00750298A patent/ZA75298B/en unknown
- 1975-01-15 FR FR7501118A patent/FR2257299B1/fr not_active Expired
- 1975-01-15 CA CA217,981A patent/CA1050966A/en not_active Expired
- 1975-01-15 IE IE78/75A patent/IE42427B1/en unknown
- 1975-01-15 IL IL46436A patent/IL46436A/en unknown
- 1975-01-15 CH CH42775A patent/CH606116A5/xx not_active IP Right Cessation
- 1975-01-15 ES ES433814A patent/ES433814A1/en not_active Expired
- 1975-01-15 GB GB1776/75A patent/GB1498132A/en not_active Expired
- 1975-01-15 NL NL7500458A patent/NL7500458A/en not_active Application Discontinuation
- 1975-01-15 FI FI750090A patent/FI750090A/fi not_active Application Discontinuation
- 1975-01-15 SE SE7500430A patent/SE7500430L/xx unknown
- 1975-01-16 SU SU7502099683A patent/SU581874A3/en active
- 1975-09-15 FR FR7528266A patent/FR2279760A1/en active Granted
Also Published As
Publication number | Publication date |
---|---|
ES433814A1 (en) | 1977-02-16 |
FR2257299A1 (en) | 1975-08-08 |
IL46436A0 (en) | 1975-06-25 |
FR2257299B1 (en) | 1978-08-04 |
DD117449A5 (en) | 1976-01-12 |
CS182829B2 (en) | 1978-05-31 |
SU581874A3 (en) | 1977-11-25 |
NL7500458A (en) | 1975-07-18 |
NO750119L (en) | 1975-07-17 |
CA1050966A (en) | 1979-03-20 |
BE824405A (en) | 1975-07-15 |
FR2279760A1 (en) | 1976-02-20 |
DK9075A (en) | 1975-09-15 |
CH606116A5 (en) | 1978-10-13 |
FR2279760B1 (en) | 1978-09-22 |
JPS50101358A (en) | 1975-08-11 |
IL46436A (en) | 1979-05-31 |
AU7731075A (en) | 1976-07-15 |
AR209758A1 (en) | 1977-05-31 |
GB1498132A (en) | 1978-01-18 |
ZA75298B (en) | 1976-01-28 |
FI750090A (en) | 1975-07-17 |
IE42427B1 (en) | 1980-08-13 |
DE2501041A1 (en) | 1975-07-17 |
SE7500430L (en) | 1975-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR840000581A (en) | How to prepare a new steroid derivative | |
DK0973791T3 (en) | Process for preparing an epoxy compound | |
NO992825D0 (en) | Methods for preparing 9,11-epoxy steroids and thereby useful intermediates | |
GB1475795A (en) | Steroid 21-thioesters | |
HU188067B (en) | Process for preparing delta 17/20/21-substituted steroids | |
GB1212273A (en) | 0,2,4-triazine-5-ones | |
AU666916B2 (en) | Novel 19-nor steroids having a thiocarbon-containing chain in the 11beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositions containing said steroids | |
GB1163737A (en) | Improvements in or relating to 7-Dihalomethyl Steroids | |
IE42427L (en) | STEROIDAL [16Ó,17Ó-b] 1,4-DIOXANES | |
IE41251B1 (en) | New 1,4-dihydropyridines and processes for their manufacture | |
US4267106A (en) | New process for the preparation 17β-hydroxy-3-oxo-17α-pregnene and pregnadiene-21-carboxylic acid γ-lactones | |
SE440505B (en) | NEW OXAZOLINE STEROID DERIVATIVES, SET FOR PREPARING THEREOF AND USING THEREOF IN THE PREPARATION OF CORTIC COSTEROIDS | |
ES359268A1 (en) | 6-gem-difluoro steroids | |
GB1436533A (en) | Aryl piperazine derivatives of adenine | |
ES8506326A1 (en) | Estrane and androstane derivatives, process for their preparation and pharmaceutical preparations containing them | |
DK0904268T3 (en) | Process for the preparation of 3- (1-hydroxyphenyl-1-alkoxyminomethyl) dioxazines | |
GB901093A (en) | Steroids | |
GB1269225A (en) | Delta9(11)-STEROIDS | |
GB1043995A (en) | Improvements in or relating to 5,10-methylene-19-nor-steroids and 5,10-seco-5,19-cyclo-10-fluoro-steroids | |
GB1502513A (en) | Steroid(16,17-b)dioxanes | |
NL8103357A (en) | NEW 20-ISONITRIL-17 (20) UNSATURATED STEROIDS, METHOD FOR PREPARING THE SAME AND METHOD FOR PREPARING 17-Alpha-HYDROXY-20-KETO STERIDS THEREOF. | |
GB1450807A (en) | Cardenolide glycosides and process for their manufacture | |
IE41382L (en) | Oxazoline derivatives. | |
KR970704671A (en) | Preparation of O- (2-hydroxyalkyl) -Oximes) | |
GB1364193A (en) | 16-alkyl-17 20 21-trihydroxy-pregna 4 9/11/-dien-3-ones and deri vatives thereof |